Our study demonstrated that ULK1 was an independent prognostic biomarker for therapeutic response in NPC, and examination of ULK1 expression by IHC method might be helpful in determining the prognosis of this tumor in clinical practice. Here, ULK1 is linked to nasopharyngeal carcinoma.